Johnson & Johnson
Symbol: JNJ (NYSE)
191.60
▼ (-1.10%) -2.125
Company Description:
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Key Stats
- Today's Open: $193.01
- Today's High: $193.565
- Today's Low: $191.595
- Today's Volume: 6.58M
- Yesterday Close: $193.72
- Yesterday High: $194.48
- Yesterday Low: $192.3346
- Yesterday Volume: 8.03M
- Last Min Volume: 13
- Last Min High: $191.595
- Last Min Low: $191.595
- Last Min VWAP: $191.595
Company Profile
- Name: Johnson & Johnson
- Website: https://www.jnj.com
- Listed Date: 1944-09-25
- Location: NEW BRUNSWICK, NJ
- Market Status: Active
- CIK Number: 0000200406
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $466.54B
- Round Lot: 100
- Outstanding Shares: 2.41B
- Asset Type: CS
RECENT FILINGS FOR JNJ
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-20 | 4 | View |
| 2025-10-17 | 144 | View |
| 2025-10-14 | 8-K | View |
| 2025-09-15 | 3 | View |
| 2025-09-11 | 4 | View |
| 2025-09-11 | 4 | View |
| 2025-09-11 | 4 | View |
| 2025-09-09 | 8-K | View |
| 2025-09-05 | 4 | View |
| 2025-09-04 | 144 | View |
| 2025-09-03 | 4 | View |
| 2025-08-29 | 144 | View |
| 2025-08-26 | N-PX | View |
| 2025-08-25 | 4 | View |
| 2025-08-22 | 144 | View |
| 2025-08-18 | 4 | View |
| 2025-08-15 | 144 | View |
| 2025-07-24 | 10-Q | View |
| 2025-07-22 | 13F-HR | View |
| 2025-07-18 | 4 | View |
Latest News on JNJ